Upcoming Live Courses

Title Credit Dates
2016 NCCN Oncology Case Manager and Medical Director Program™ - Distress Management – Implementing New Standards of Care
  • 1.25 CCM clock hours credits
  • 1.25 ANCC contact hours credits
  • 1.25 AMA PRA Category 1 Credit™ credits
  • 1.25 Participation credits
12/12/2016 - 4:00pm to 5:15pm
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Myeloproliferative Neoplasms: Myelofibrosis
  • 1.00 CCM clock hours credit
  • 1.00 ACPE contact hours credit
  • 1.00 ANCC contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 Participation credit
12/13/2016 - 9:15am to 10:15am
2016 NCCN Oncology Case Manager and Medical Director Program™ - Ovarian Cancer – The Value of NCCN Guideline-Adherent Care
  • 1.25 CCM clock hours credits
  • 1.25 ANCC contact hours credits
  • 1.25 AMA PRA Category 1 Credit™ credits
  • 1.25 Participation credits
12/14/2016 - 1:30pm to 2:45pm
2016 NCCN Oncology Case Manager and Medical Director Program™ - Practical Considerations in the Long-Term Management of Patients with CML
  • 1.25 CCM clock hours credits
  • 1.25 ANCC contact hours credits
  • 1.25 AMA PRA Category 1 Credit™ credits
  • 1.25 Participation credits
12/16/2016 - 11:00am to 12:15pm
NCCN 2016 Congress Webinar Series: Immunotherapies in Cancer - Management of Toxicities Related to Immunotherapies
  • 1.00 ACPE contact hours credit
  • 1.00 ANCC contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 Participation credit
12/21/2016 - 3:00pm to 4:00pm

Pages

Featured Courses

Title Credit Type
The Future of Targeted Therapies for Acute Myeloid Leukemia
  • 0.75 ACPE contact hours credits
  • 0.79 ANCC contact hours credits
  • 0.75 AMA PRA Category 1 Credit™ credits
  • 0.75 Participation credits
Enduring
NCCN Guidelines® Insights - Bladder Cancer, Version 2.2016
  • 1.00 ACPE contact hours credit
  • 1.00 ANCC contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 Participation credit
Enduring
NCCN Guidelines® Insights - Non-Hodgkin’s Lymphomas, Version 3.2016
  • 1.00 ACPE contact hours credit
  • 1.00 ANCC contact hours credit
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 Participation credit
Enduring
Does Generic Imatinib Change the Treatment Approach in CML?
  • 0.50 ACPE contact hours credits
  • 0.39 ANCC contact hours credits
  • 0.50 AMA PRA Category 1 Credit™ credits
  • 0.50 Participation credits
Enduring
How to Integrate the New Drugs into Therapy of Myeloma
  • 0.25 ACPE contact hours credits
  • 0.33 ANCC contact hours credits
  • 0.25 AMA PRA Category 1 Credit™ credits
  • 0.25 Participation credits
Enduring

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.